WHITNEY PERRY: Open Payments
NPI 1669773511 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 46 payments from 19 companies in 2025. Trend: 2023 $1,135 · 2024 $1,353 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $156 |
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
| Merck Sharp & Dohme LLC | 7 | $130 |
| Daiichi Sankyo Inc. | 6 | $125 |
| Incyte Corporation | 3 | $78 |
| PFIZER INC. | 3 | $65 |
| ABBVIE INC. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| GENZYME CORPORATION | 2 | $41 |
| Syndax Pharmaceuticals, Inc. | 2 | $39 |
Products named: REBLOZYL, KEYTRUDA, Enhertu, KISQALI, SCEMBLIX, Fabhalta, AYVAKIT, INJECTAFER.
Industry payments across KY — which companies pay providers there.
